Agilon Health, Inc. (AGL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.42B | 1.57B | 1.44B | 1.39B | 1.53B | 1.52B | 1.45B | 1.48B | 1.6B | 815.5M | 1.14B | 1.07B |
| Revenue Growth % | -7.33% | 3.09% | -1.08% | -5.92% | -4.46% | 86.69% | 27.63% | 38.69% | 52.17% | 18.23% | 63.61% | 59.54% |
| Cost of Goods Sold | 0 | 1.67B | 1.5B | 1.45B | 1.48B | 1.56B | 1.52B | 1.45B | 1.53B | 910.8M | 1.1B | 1.01B |
| COGS % of Revenue | - | 106.22% | 104.71% | 103.76% | 96.69% | 102.51% | 104.42% | 97.83% | 95.32% | 111.69% | 96.76% | 94.9% |
| Gross Profit | 0 | -97.64M | -67.65M | -52.43M | 50.72M | -38.26M | -64.17M | 32.17M | 75.09M | -95.3M | 36.84M | 54.58M |
| Gross Margin % | - | -6.22% | -4.71% | -3.76% | 3.31% | -2.51% | -4.42% | 2.17% | 4.68% | -11.69% | 3.24% | 5.1% |
| Gross Profit Growth % | -100% | -155.23% | -5.42% | -262.94% | -32.45% | 59.86% | -274.18% | -41.05% | 2.69% | -1053.34% | 42.17% | 60.92% |
| Operating Expenses | 54.23M | 58.12M | 63.63M | 63.6M | 72.83M | 69.84M | 69.34M | 75.52M | 82.27M | 64.31M | 76.13M | 83.53M |
| OpEx % of Revenue | 3.82% | 3.7% | 4.43% | 4.56% | 4.75% | 4.59% | 4.78% | 5.09% | 5.13% | 7.89% | 6.7% | 7.81% |
| Selling, General & Admin | 54.23M | 60.1M | 56.2M | 56.28M | 65.96M | 59.76M | 63.12M | 69.61M | 76.42M | 63.28M | 72.06M | 79.25M |
| SG&A % of Revenue | 3.82% | 3.83% | 3.92% | 4.03% | 4.3% | 3.92% | 4.35% | 4.69% | 4.76% | 7.76% | 6.34% | 7.41% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 4M | -155.76M | -131.27M | -116.03M | -22.11M | -108.1M | -133.51M | -43.34M | -7.18M | -159.6M | -39.29M | -28.96M |
| Operating Margin % | 0.28% | -9.92% | -9.15% | -8.32% | -1.44% | -7.1% | -9.2% | -2.92% | -0.45% | -19.57% | -3.46% | -2.71% |
| Operating Income Growth % | 118.08% | -44.09% | 1.67% | -167.69% | -208.02% | 32.27% | -239.77% | -49.68% | -1821.34% | -130.91% | -33.12% | -37.55% |
| EBITDA | 10.78M | -148.79M | -123.84M | -108.71M | -15.23M | -101.61M | -127.29M | -37.44M | -1.33M | -154.46M | -33.98M | -23.44M |
| EBITDA Margin % | 0.76% | -9.48% | -8.63% | -7.79% | -0.99% | -6.67% | -8.77% | -2.52% | -0.08% | -18.94% | -2.99% | -2.19% |
| EBITDA Growth % | 170.79% | -46.44% | 2.71% | -190.38% | -1041.98% | 34.22% | -274.56% | -59.7% | -128.96% | -136.85% | -30.37% | -30.16% |
| D&A (Non-Cash Add-back) | 6.79M | 6.97M | 7.43M | 7.32M | 6.88M | 6.49M | 6.22M | 5.91M | 5.84M | 5.15M | 5.31M | 5.51M |
| EBIT | 0 | -185.84M | -108.7M | -102.74M | -177K | -103.1M | -115.4M | -28.55M | 4.4M | -160.78M | -19.21M | -13.4M |
| Net Interest Income | 1.81M | -1.72M | -1.84M | -1.57M | -1.51M | -1.57M | -1.62M | -1.7M | -1.28M | -1.89M | -1.62M | -1.55M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -1.81M | 1.72M | 1.84M | 1.57M | 1.51M | 1.57M | 1.62M | 1.7M | 1.28M | 1.89M | 1.62M | 1.55M |
| Other Income/Expense | 25.95M | -31.8M | 20.74M | 11.72M | 20.42M | 3.43M | 16.49M | 13.1M | 10.29M | -3.06M | 18.46M | 14M |
| Pretax Income | 29.94M | -187.56M | -110.54M | -104.31M | -1.69M | -104.67M | -117.02M | -30.25M | 3.11M | -162.67M | -20.83M | -14.95M |
| Pretax Margin % | 2.11% | -11.95% | -7.7% | -7.48% | -0.11% | -6.88% | -8.07% | -2.04% | 0.19% | -19.95% | -1.83% | -1.4% |
| Income Tax | -28K | 1.32M | -331K | 62K | 196K | 1.76M | -590K | 417K | -133K | 267K | 1.21M | 1.07M |
| Effective Tax Rate % | -0.09% | -0.71% | 0.3% | -0.06% | -11.58% | -1.68% | 0.5% | -1.38% | -4.27% | -0.16% | -5.81% | -7.18% |
| Net Income | 29.97M | -188.88M | -110.21M | -104.37M | 12.11M | -105.79M | -117.61M | -30.68M | -6.06M | -230.43M | -31.44M | -16.75M |
| Net Margin % | 2.11% | -12.03% | -7.68% | -7.48% | 0.79% | -6.95% | -8.11% | -2.07% | -0.38% | -28.26% | -2.77% | -1.57% |
| Net Income Growth % | 147.46% | -78.54% | 6.3% | -240.17% | 299.74% | 54.09% | -274.14% | -83.19% | -137.85% | -308.09% | -2.5% | 18.89% |
| Net Income (Continuing) | 29.97M | -188.88M | -110.21M | -104.37M | -1.89M | -106.43M | -116.43M | -30.66M | 3.25M | -162.93M | -22.04M | -16.03M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 1000K | 640K | -1000K | 0 | -1000K | -1000K | -1000K | -769K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -768K | -788K | -818K | -767K | -720K |
| EPS (Diluted) | 1.80 | -11.50 | -6.75 | -6.25 | 0.75 | -6.50 | -7.25 | -1.75 | -0.25 | -14.00 | -2.00 | -1.00 |
| EPS Growth % | 140% | -76.92% | 6.9% | -257.14% | 400% | 53.57% | -262.5% | -75% | -125% | -300% | -14.29% | 20% |
| EPS (Basic) | 1.80 | -11.50 | -6.75 | -6.25 | 0.75 | -6.50 | -7.25 | -1.75 | -0.25 | -14.00 | -2.00 | -1.00 |
| Diluted Shares Outstanding | 16.66M | 16.58M | 16.58M | 16.55M | 16.52M | 16.48M | 16.46M | 16.45M | 16.36M | 16.36M | 16.23M | 16.41M |
| Basic Shares Outstanding | 16.6M | 16.58M | 16.58M | 16.55M | 16.52M | 16.48M | 16.46M | 16.45M | 16.36M | 16.36M | 16.23M | 16.41M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |